RFPs: Pfizer Clostridioides difficile (C. difficile) Research Collaboration Program

Pfizer has announced a Request for Proposals for its 2026 Vaccine Access and Global CDI (Clostridioides difficile infection) program aimed at improving vaccine access and addressing global health challenges. The focus areas include improving vaccine access in underserved populations, supporting innovative solutions for vaccine delivery, increasing awareness and education around vaccines, strengthening health systems to

Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members:

Subscribe Now

Scroll to Top